| LDR | | 01656nmm uu200421 4500 |
| 001 | | 000000333950 |
| 005 | | 20240805174838 |
| 008 | | 181129s2018 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438175334 |
| 035 | |
▼a (MiAaPQ)AAI10827163 |
| 035 | |
▼a (MiAaPQ)washington:18634 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 082 | 0 |
▼a 615 |
| 100 | 1 |
▼a Kraft, John Cavin, II. |
| 245 | 10 |
▼a Elucidating Mechanisms for Drug Combination Nanoparticles to Enhance and Prolong Lymphatic Exposure: Experimental and Modeling Approaches. |
| 260 | |
▼a [S.l.] :
▼b University of Washington.,
▼c 2018 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2018 |
| 300 | |
▼a 253 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B. |
| 500 | |
▼a Adviser: Rodney J. Y. Ho. |
| 502 | 1 |
▼a Thesis (Ph.D.)--University of Washington, 2018. |
| 520 | |
▼a Human immunodeficiency virus (HIV) infection and metastatic cancers impact over 50 million people worldwide. Because HIV and metastatic cancers exploit the lymphatics to persist and spread, enhanced and prolonged lymphatic exposure to drug combi |
| 590 | |
▼a School code: 0250. |
| 650 | 4 |
▼a Pharmaceutical sciences. |
| 650 | 4 |
▼a Medical imaging. |
| 650 | 4 |
▼a Medicine. |
| 690 | |
▼a 0572 |
| 690 | |
▼a 0574 |
| 690 | |
▼a 0564 |
| 710 | 20 |
▼a University of Washington.
▼b Pharmaceutics. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-12B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0250 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14998990
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자 |